NSQIP^® Indexed Complications Following Transurethral Bladder Tumor Resection and Contemporary Financial Implications

Area of Science:

• Urology
• Surgical Oncology
• Health Economics

Background:

• The National Surgical Quality Improvement Project (NSQIP) provides valuable data on surgical outcomes.
• Understanding the relationship between tumor size and complications is crucial for patient care and resource allocation.

Purpose of the Study:

• To determine the incidence of NSQIP-indexed complications based on tumor size during transurethral bladder tumor resection.
• To investigate the financial implications of these complications using current reimbursement schedules.

Main Methods:

• Retrospective analysis of 8,116 transurethral bladder tumor resections from 2010-2012.
• Stratification of procedures by tumor size using CPT codes.
• Comparison of preoperative characteristics, surgical parameters, and 30-day outcomes using statistical tests.
• Analysis of institutional financial data and Medicare reimbursement schedules.

Main Results:

• Larger tumor resections were associated with significantly longer operative times, increased length of hospital stay, and higher rates of transfusion, sepsis, and renal insufficiency.
• Increased rates of 30-day mortality, readmission, and reoperation were observed with larger tumor sizes.
• Common Diagnosis Related Group classifications for inpatient procedures resulted in operating losses for Medicare beneficiaries.

Conclusions:

• The coding selected by urologists directly correlates with NSQIP-indexed postoperative complications.
• Transurethral bladder tumor resections, particularly those with complications, may lead to financial losses for healthcare institutions.
• Improvements in quality of care and reimbursement strategies are necessary to address these financial challenges.